Notice of Issuance of New Shares
The Company hereby gives notice pursuant to Article 418 Paragraph 4 of the Commercial Act that the Board of Directors resolved on January 16, 2026 to issue new shares in connection with the listing on the KOSDAQ Market as follows.
1. Type and number of new shares : Registered common shares: 1,385,350 – 1,398,800 shares (par value KRW 500)
Classification | Type of Securities | Offering | Par Value | Number |
New Share Offering | Registered | Public | KRW 500 | 1,345,000 |
Underwriter Mandatory Subscription | Registered | Private | KRW 500 | 40,350 shares |
Underwriter Mandatory Acquisition | Registered | Private | KRW 500 | 0 – 13,450 |
2. Offering Price
In accordance with Article 5 of the “Regulations on Underwriting Business of Securities,” the final offering price shall be determined by the Chief Executive Officer in consultation with Shinhan Securities Co., Ltd., the lead underwriter for the Company’s KOSDAQ listing, taking into account the results of the demand forecast and market conditions.
3. Allocation of the Offered Shares
1) The offered shares shall be allocated in accordance with Article 9 of the Regulations on Underwriting Business of Securities.
2) The allocation method and detailed terms may be changed based on the results of the demand forecast and subscription, and the detailed plan shall be delegated to the Chief Executive Officer.
4. Method of Underwriting
All of the offered shares shall be fully underwritten (100%) by the lead underwriter, Shinhan Securities Co., Ltd., and other matters shall be determined by the Chief Executive Officer.
5. Payment Date : March 19, 2026 (scheduled)
The payment date may be determined by the Chief Executive Officer depending on the effective date of the securities registration statement filed with the Financial Supervisory Service and the offering schedule.
6. Paying Bank : Shinhan Bank, Wonju Financial Center
(If changes are required, the authority to determine such changes shall be delegated to the Chief Executive Officer.)
7. Preemptive Rights : In accordance with Article 10 Paragraph 2 of the Articles of Incorporation of the Company, the preemptive rights of existing shareholders shall be excluded.
8. Contribution in Kind : Not applicable.
9. Other Matters
The above matters may be changed depending on the results of demand forecasting and consultation with shareholders and the lead underwriter. Detailed matters are delegated to the Chief Executive Officer.
March 3, 2026
MEZOO Co., Ltd.
808, 200 Gieopdosi-ro, Jijeong-myeon
Wonju-si, Gangwon Special Self-Governing Province, Republic of Korea
(Medical Device Industry Support Center)
Chief Executive Officer
Jung Hwan Park
